Ignite Creation Date:
2024-05-05 @ 10:17 AM
Last Modification Date:
2024-10-26 @ 9:02 AM
Study NCT ID:
NCT00001620
Status:
ENROLLING_BY_INVITATION
Last Update Posted:
2024-07-01
First Post:
1999-11-03
Brief Title:
Screening for Hematology Branch Protocols
Sponsor:
National Heart Lung and Blood Institute NHLBI
Organization:
National Institutes of Health Clinical Center CC
Study Overview
Official Title:
Screening Protocol for Subjects Being Evaluated for National Heart Lung and Blood Institute NHLBI Protocols
Status:
ENROLLING_BY_INVITATION
Status Verified Date:
2024-05-16
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study allows the evaluation of subjects in order to determine their ability to safely participate in other active research studies
After subjects complete the screening process they will be offered the opportunity to participate in an active research study or if no appropriate studies are available information and recommendations will be provided for other treatment options
After subjects complete the screening process they will be offered the opportunity to participate in an active research study or if no appropriate studies are available information and recommendations will be provided for other treatment options
Detailed Description:
This protocol is designed for screening of subjects before a decision can be made as to their eligibility for one of the active National Heart Lung and Blood Institute NHLBI research protocols Its purpose is to allow detailed investigation into the hematologic or oncologic problems of these subjects and the status of other organ systems that would determine their ability to safely tolerate specific aspects of active research protocols It allows investigation as to whether a donor is HLA matched fit to receive G-CSF and fit to undergo apheresis and therefore eligible to participate as a donor on a bone marrow transplant protocol It also allows the investigation as to whether subjects are eligible for participation as normal volunteer based on protocol eligibility criteria that requires generally good health status by history or physical exam findings or laboratory assessments After completion of this screening process the subject will either be offered a chance to participate in an active research protocol or if no appropriate protocol is identified subjects with hematologic or oncologic disease will have recommendations for other treatment options relayed to the primary or referring physician
Primary objective is to determine subject eligibility for participation on NHLBI protocols
Primary endpoint is the results of clinical imaging and laboratory assessments
Primary objective is to determine subject eligibility for participation on NHLBI protocols
Primary endpoint is the results of clinical imaging and laboratory assessments
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 97-H-0041 | None | None | None |